EUVIMEDEUVIMED entdecken
Crossref

Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry

Naveen Kumar Dubey iD, Peeyush Jain, Ankit Raj, Sandeep Tiwari

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Naveen Kumar Dubey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jubilant Generics Limited, Noida, India. Hauptthemen laut MEDLINE: Alanine, Adenosine Monophosphate, Tandem Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to assess the pharmacokinetics of the existing remdesivir intravenous formulation (100 mg dose) against the newly developed oral formulation (20 mg dose) for remdesivir and its active nucleoside metabolite (GS‐441524) in beagle dogs followed by healthy human volunteers. A quantification method for remdesivir and its active nucleoside metabolite (GS‐441524) in beagle dog and human plasma has been developed and validated using liquid chromatography coupled to triple quadrupole mass spectrometry detection. The analytical methods for beagle dogs and human differ in the calibration curve range, plasma matrix, processing volume, reconstitution volume and injection volume; however all other parameters were same in both methods. A simple protein precipitation extraction was carried out using acetonitrile containing the internal standard remdesivir D5. Remdesivir and GS‐441524 were separated on an Endurus C‐18P, 100 × 4.6 mm, 3 μm column and detected using a mass spectrometer with electrospray ionization in positive ion mode. The ion transitions used were m / z 603.1 → m / z 200.0 for remdesivir, m / z 292.0 → m / z 202.2 for GS‐441524 and m / z 608.2 → m / z 205.1 for remdesivir D5. The calibration curve results were linear in beagle dog plasma (2.0–2,000.8 ng/ml range for remdesivir and 2.0–1,500.4 ng/ml for GS‐441524) and human plasma (30.0–4,503.9 ng/ml range for remdesivir and 2.0–200.4 ng/ml for GS‐441524). The recovery was >90% in beagle dog and human plasma. These methods were successfully used to determine the pharmacokinetic parameters of the intravenous injection and subcutaneous tablets dosage forms in beagle dogs and healthy humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlanineAdenosine MonophosphateTandem Mass SpectrometryDogsAnimalsHumansReproducibility of ResultsMaleChromatography, LiquidAntiviral AgentsLinear ModelsAdultFemaleLimit of DetectionAdenosine

Stichwörter der Autor:innen

LC–MS/MSbeagle dog plasmahuman plasmanucleoside metabolite (GS‐441524)remdesivir

Substanzen

remdesivirAlanineAdenosine MonophosphateGS-441524Antiviral AgentsAdenosine

Autor:innen und Institutionen

  • Jubilant Generics Limited, Noida, India.

ORCID-Profile: Naveen Kumar Dubey

Zitieren

APA

Dubey, N. K., Jain, P., Raj, A., & Tiwari, S. (2024). Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry. Biomedical Chromatography. https://doi.org/10.1002/bmc.5965

Vancouver

Dubey NK, Jain P, Raj A, Tiwari S. Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry. Biomedical Chromatography. 2024. doi:10.1002/bmc.5965

BibTeX
@article{Dubey2024,
  author = {Dubey, Naveen Kumar and Jain, Peeyush and Raj, Ankit and Tiwari, Sandeep},
  title = {Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5965}
}
Kostenlos starten →